Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | ACR | P10323 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SERPINE1 | P05121 | 4/20 | 0.32 |
| ▸ | CLK2 | P49760 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9970899 | 0.96 | NSD2 (0.41) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL9970804 | 0.95 | MAPT (0.36) | PRSS1ACRMAPTTDP1L3MBTL1 | |
| SCHEMBL9970833 | 0.93 | NSD2 (0.44) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL9970807 | 0.92 | MAPT (0.38) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL9970805 | 0.86 | MAPT (0.39) | PRSS1ACRMAPTTDP1L3MBTL1 | |
| SCHEMBL9970893 | 0.83 | MAPT (0.41) | PRSS1ACRMAPTTDP1L3MBTL1 | |
| SCHEMBL9967353 | 0.78 | NSD2 (0.52) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL9967358 | 0.73 | NSD2 (0.58) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL9967352 | 0.72 | TDP1 (0.49) | NSD2PRSS1ACRMAPTTDP1 | |
| SCHEMBL14473664 | 0.70 | MAPT (0.50) | PRSS1ACRMAPTTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120156614-A1 | Novel Phenol Compounds and Positive Photosensitive Resin Composition Including the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156614-A1 | Novel Phenol Compounds and Positive Photosensitive Resin Composition Including the Same | SUN2, TYR, PSMD2 | NSD2 568/4885PRSS1 2506/4885ACR 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.